mitochondrial ribosomal protein S15 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored MRPS15P1 profile across patient tissues and cancer cell-line models. MRPS15P1 expression is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, MRPS15P1 is differentially expressed in 3, with the highest sampling consensus in READ. Additionally, MRPS15P1 RNA expression shows 6,599 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight MESO, READ, and STAD as cancer lineages where MRPS15P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MRPS15P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MRPS15P1 survival associations across molecular data types. MRPS15P1 RNA expression shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MRPS15P1 RNA expression–survival associations across cancer types. High MRPS15P1 expression shows unfavorable associations in MESO, OV, KIRC, LUSC, UVM and UCEC. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .016). Together, the overview and detailed table identify MESO as the clearest survival context for MRPS15P1 RNA expression.
This table summarizes MRPS15P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in READ for RNA.
This table ranks reproducible tumor–normal expression differences for MRPS15P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MRPS15P1 shows lower tumor expression in READ and THCA and higher tumor expression in STAD. The READ box plot shows higher MRPS15P1 RNA expression in normal versus tumor tissue (log2 FC = −0.096, t-test p = .011).
This table shows molecular features associated with MRPS15P1 in patient tissues and cancer cell lines. In patient samples, MRPS15P1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
